ストックスクリーナーアプリを入手
23.65
1.13%
-0.27
アフターアワーズ：
23.66
0.01
+0.04%
前日終値:
$23.92
開ける：
$23.81
24時間の取引高:
486.61K
Relative Volume:
1.22
時価総額：
$13.88B
収益：
$21.23B
当期純損益:
$924.30M
株価収益率:
19.27
EPS:
1.2272
ネットキャッシュフロー:
$2.22B
1週間 パフォーマンス:
-0.42%
1か月 パフォーマンス:
-11.89%
6か月 パフォーマンス:
-16.73%
1年 パフォーマンス:
+7.40%
1日の値動き範囲:
$23.63
$23.87
1週間の範囲:
$23.63
$24.20
52週間の値動き範囲:
$22.05
$30.46
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
FMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
23.65 | 13.87B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
HCA
Hca Healthcare Inc
|
503.00 | 115.99B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
215.13 | 19.06B | 20.69B | 2.40B | 1.55B | 15.62 |
|
UHS
Universal Health Services Inc
|
239.43 | 15.22B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
114.70 | 11.69B | 5.51B | 494.70M | 386.40M | 4.84 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2025-09-02 | ダウングレード | UBS | Neutral → Sell |
| 2024-12-02 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-11-06 | 開始されました | Berenberg | Buy |
| 2024-01-08 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | アップグレード | HSBC Securities | Reduce → Hold |
| 2023-11-17 | アップグレード | Societe Generale | Hold → Buy |
| 2023-08-14 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-01 | 再開されました | Citigroup | Neutral |
| 2023-07-12 | 開始されました | Goldman | Buy |
| 2023-03-07 | 開始されました | Bernstein | Mkt Perform |
| 2023-01-03 | ダウングレード | Jefferies | Buy → Underperform |
| 2022-10-26 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-10-10 | ダウングレード | Jefferies | Buy → Hold |
| 2022-06-27 | アップグレード | Jefferies | Underperform → Buy |
| 2022-02-11 | ダウングレード | Jefferies | Hold → Underperform |
| 2021-11-23 | 開始されました | HSBC Securities | Hold |
| 2021-11-11 | アップグレード | Jefferies | Underperform → Hold |
| 2021-02-04 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-02-03 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2020-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2020-05-20 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | アップグレード | Jefferies | Hold → Buy |
| 2019-06-20 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-12-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | アップグレード | UBS | Neutral → Buy |
| 2018-08-28 | アップグレード | HSBC Securities | Hold → Buy |
| 2018-07-05 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | アップグレード | UBS | Sell → Neutral |
| 2017-12-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | アップグレード | Citigroup | Neutral → Buy |
| 2016-07-08 | アップグレード | Jefferies | Underperform → Hold |
| 2016-01-04 | アップグレード | JP Morgan | Neutral → Overweight |
| 2015-11-04 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | アップグレード | Goldman | Neutral → Buy |
| 2015-08-13 | ダウングレード | Societe Generale | Buy → Hold |
| 2015-07-31 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | 繰り返されました | Feltl & Co. | Hold |
| 2013-01-14 | アップグレード | HSBC Securities | Neutral → Overweight |
すべてを表示
Fresenius Medical Care Ag Adr (FMS) 最新ニュース
Alphabet Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
U.S. Arteriovenous Fistula Devices Market Trends Analysis Report 2025-2033: Lucrative Opportunities Stem from Rising ESRD Cases, Driving Demand for AVF Solutions - GlobeNewswire Inc.
Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Fresenius Medical Care launches €500 million bond offering - Investing.com India
Living well with diabetes and beyond - Fresenius Medical Care
FMS Stock Price and Chart — NYSE:FMS - TradingView
Diabetes and Well-being: Interview with Dr. Hippen - Fresenius Medical Care
Fresenius Medical Care marks World Diabetes Day 2025: Living well with diabetes and beyond - Fresenius Medical Care
The Best Healthcare Stocks to Buy - Morningstar
FMS Stock Rises as Q3 Earnings Beat Estimates, Revenues Gain Y/Y - Finviz
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025 - Fresenius Medical Care
Fresenius Medical Care reports strong Q3 with 8.3% revenue growth - Investing.com
Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025 - Fresenius Medical Care
Fresenius Medical Care Again Named to Top 100 Women-Led Businesses in Massachusetts - Fresenius Medical Care
Research in brief: Time on treatment - Fresenius Medical Care
Bank of America Securities downgrades Fresenius Medical Care AG & Co. KGaA (0H9X) to a Sell - The Globe and Mail
BofA Securities downgrades Fresenius Medical Care stock on volume concerns - Investing.com
Fresenius Medical Care stock rating downgraded to underperform by BofA - Investing.com South Africa
Fresenius Medical Care stock downgraded by BofA on patient volume concerns - Investing.com Nigeria
Fresenius Medical Care Appoints Joseph Turk to Management Board - The Globe and Mail
Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement - Fresenius Medical Care
Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment - freseniusmedicalcare.com
Fresenius Medical Care Celebrates Nephrology Nurses Week with The CARE Award - freseniusmedicalcare.com
UBS downgrades Fresenius Medical Care to “sell,” warns on U.S. dialysis outlook - Investing.com
Fresenius Medical Care launches €600 million share buyback tranche - Investing.com
Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework - freseniusmedicalcare.com
Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025 - freseniusmedicalcare.com
Fresenius Medical Care ADR earnings beat by $0.41, revenue fell short of estimates - Investing.com Australia
Fresenius Medical Care Q2 results show revenue growth despite challenges - Investing.com
Fresenius Medical Care’s Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care - freseniusmedicalcare.com
Is The Options Market Predicting A Spike In Fresenius Medical Stock? - Barchart.com
"I’m in My Living Life Era”: Katelyn’s Double Transplant Journey - Fresenius Medical Care
Kidney transplantation and value-based care - Fresenius Medical Care
Why I love home dialysis as a HCP working in nephrology - Fresenius Medical Care
Fresenius Medical Care Ag Adr (FMS) 財務データ
収益
当期純利益
現金流量
EPS
1.72%
大文字化:
|
ボリューム (24 時間):